157 related articles for article (PubMed ID: 16183564)
21. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
[TBL] [Abstract][Full Text] [Related]
22. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
23. Nesiritide compared with milrinone for cardiac surgery.
Blais DM
Ann Pharmacother; 2007 Mar; 41(3):502-4. PubMed ID: 17327288
[TBL] [Abstract][Full Text] [Related]
24. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
Bredin F; Liska J; Franco-Cereceda A
Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
[TBL] [Abstract][Full Text] [Related]
25. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.
Melenovsky V; Al-Hiti H; Kazdova L; Jabor A; Syrovatka P; Malek I; Kettner J; Kautzner J
J Am Coll Cardiol; 2009 Aug; 54(7):595-600. PubMed ID: 19660688
[TBL] [Abstract][Full Text] [Related]
26. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study.
Chen HH; Sundt TM; Cook DJ; Heublein DM; Burnett JC
Circulation; 2007 Sep; 116(11 Suppl):I134-8. PubMed ID: 17846293
[TBL] [Abstract][Full Text] [Related]
27. Clinical status and B-type natriuretic peptide levels in patients with heart failure at hospital discharge.
Oral I; Mistrík J; Náplava R
Herz; 2007 Oct; 32(7):583-8. PubMed ID: 17972033
[TBL] [Abstract][Full Text] [Related]
28. N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.
Walsh R; Boyer C; LaCorte J; Parnell V; Sison C; Chowdhury D; Ojamaa K
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):98-105. PubMed ID: 18179925
[TBL] [Abstract][Full Text] [Related]
29. Brain natriuretic peptide: clinical and research challenges.
Carrillo-Jimenez R; Borzak S; Hennekens CH
J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):85-8. PubMed ID: 17562778
[TBL] [Abstract][Full Text] [Related]
30. Independent value of echocardiography and N-terminal pro-natriuretic Peptide for the prediction of major outcomes in patients with suspected heart failure.
Lim TK; Hayat SA; Gaze D; Celik E; Collinson P; Senior R
Am J Cardiol; 2007 Sep; 100(5):870-5. PubMed ID: 17719336
[TBL] [Abstract][Full Text] [Related]
31. Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker.
Shih CY; Sapru A; Oishi P; Azakie A; Karl TR; Harmon C; Asija R; Adatia I; Fineman JR
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):632-8. PubMed ID: 16515916
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of nesiritide in pediatric heart failure.
Jefferies JL; Price JF; Denfield SW; Chang AC; Dreyer WJ; McMahon CJ; Grenier MA; Clunie SK; Thomas A; Moffett BS; Wann TS; Smith EO; Towbin JA
J Card Fail; 2007 Sep; 13(7):541-8. PubMed ID: 17826644
[TBL] [Abstract][Full Text] [Related]
33. Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease.
Koch A; Kitzsteiner T; Zink S; Cesnjevar R; Singer H
Int J Cardiol; 2007 Jan; 114(3):339-44. PubMed ID: 16753233
[TBL] [Abstract][Full Text] [Related]
34. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
35. Beta-blockers influence the short-term and long-term prognostic information of natriuretic peptides and catecholamines in chronic heart failure independent from specific agents.
Frankenstein L; Nelles M; Slavutsky M; Schellberg D; Doesch A; Katus H; Remppis A; Zugck C
J Heart Lung Transplant; 2007 Oct; 26(10):1033-9. PubMed ID: 17919624
[TBL] [Abstract][Full Text] [Related]
36. B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery.
Hsu JH; Keller RL; Chikovani O; Cheng H; Hollander SA; Karl TR; Azakie A; Adatia I; Oishi P; Fineman JR
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):939-45. PubMed ID: 17903511
[TBL] [Abstract][Full Text] [Related]
37. Risk stratification in neonates and infants submitted to cardiac surgery with cardiopulmonary bypass: a multimarker approach combining inflammatory mediators, N-terminal pro-B-type natriuretic peptide and troponin I.
Carmona F; Manso PH; Vicente WV; Castro M; Carlotti AP
Cytokine; 2008 Jun; 42(3):317-24. PubMed ID: 18417355
[TBL] [Abstract][Full Text] [Related]
38. Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: time courses and prediction of response.
Boriani G; Regoli F; Saporito D; Martignani C; Toselli T; Biffi M; Francolini G; Diemberger I; Bacchi L; Rapezzi C; Ferrari R; Branzi A
Peptides; 2006 Jul; 27(7):1776-86. PubMed ID: 16621149
[TBL] [Abstract][Full Text] [Related]
39. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
Vesely DL
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
[TBL] [Abstract][Full Text] [Related]
40. Altered cardiac function.
Steele L; Webster NR
J R Coll Surg Edinb; 2001 Feb; 46(1):29-34. PubMed ID: 11242740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
